Anhui HeartVoice Medical Technology Co., Ltd. is an AI medical technology enterprise. Its founding team comes from University of Science and Technology of China, Peking University and Huawei.
HeartVoice applies the new generation of AI technology such as deep learning to automatic analysis and diagnosis of electrocardiogram (ECG). HeartVoice is committed to reducing the cost of ECG diagnosis to less than 10% of the current situation of the industry with the accuracy comparable to human experts. HeartVoice was founded in 2017 and completed Angel round financing at the time of its establishment, with an estimated value of 50 million RMB.

intellectual property

11 invention patents have been published and verified, and 7 software copyrights and 1 design patent have been obtained

Honors won

Golden Award, China “Internet+” Innovation and Entrepreneurship Competition, 2019
Red Dot Design Award and Good Design Award, 2019
Second Place, the MedAI world AI Innovation Challenge ECG track
First Place, the 18th PhysioNet/Computing in Cardiology Challenge, 2017
Contact Us